Sara Nelson Glick1, Richard Burt2, Kim Kummer3, Joe Tinsley2, Caleb J Banta-Green4, Matthew R Golden5. 1. Division of Allergy and Infectious Diseases, University of Washington, SLU Building E, Box 358062, Seattle, WA, 98195, United States; HIV/STD Program, Public Health - Seattle and King County, 401 5th Ave, Suite 1250, Seattle, WA, 98104, United States. Electronic address: snglick@uw.edu. 2. HIV/STD Program, Public Health - Seattle and King County, 401 5th Ave, Suite 1250, Seattle, WA, 98104, United States. 3. Department of Epidemiology, University of Washington, 1959 NE Pacific Street, Health Sciences Building, F-262, Box 357236, Seattle, WA, 98195, United States. 4. Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th Street, Suite 120, Box 354805, Seattle, WA, 98105, United States. 5. Division of Allergy and Infectious Diseases, University of Washington, SLU Building E, Box 358062, Seattle, WA, 98195, United States; HIV/STD Program, Public Health - Seattle and King County, 401 5th Ave, Suite 1250, Seattle, WA, 98104, United States.
Abstract
BACKGROUND: In King County, Washington, the HIV prevalence among men who have sex with men (MSM) who inject methamphetamine is high, while it is low among other people who inject drugs (PWID). Local drug problem indicators suggest that methamphetamine use is increasing. The extent to which this increase affects MSM and non-MSM, and whether MSM and non-MSM networks are connected through injection equipment sharing, is unknown. METHODS: We used data from two serial cross-sectional surveys of PWID including five biannual surveys of Public Health-Seattle and King County Needle and Syringe Exchange Program clients (NSEP, N=2135, 2009-2017) and three National HIV Behavioral Surveillance IDU surveys (NHBS, N=1709, 2009-2015). RESULTS: The proportion of non-MSM PWID reporting any recent methamphetamine injection increased significantly from approximately 20% in 2009 to 65% in 2017. Most of this increase was attributable to injecting methamphetamine in combination with heroin (goofballs). PWID who injected goofballs were more likely to be younger, homeless or unstably housed, report daily injection, and self-report an opioid overdose in the past year than other PWID. The majority of PWID who injected methamphetamine reported sharing any injection equipment. Among these PWID, 43% of MSM had last shared injection equipment with a non-MSM. Eight percent of non-MSM men and 15% of women had last shared equipment with an MSM. CONCLUSIONS: Given non-trivial rates of sharing injection equipment with methamphetamine-using MSM, a population with an HIV prevalence of 40%, non-MSM who inject methamphetamine could be an emerging population at risk for acquiring HIV.
BACKGROUND: In King County, Washington, the HIV prevalence among men who have sex with men (MSM) who inject methamphetamine is high, while it is low among other people who inject drugs (PWID). Local drug problem indicators suggest that methamphetamine use is increasing. The extent to which this increase affects MSM and non-MSM, and whether MSM and non-MSM networks are connected through injection equipment sharing, is unknown. METHODS: We used data from two serial cross-sectional surveys of PWID including five biannual surveys of Public Health-Seattle and King County Needle and Syringe Exchange Program clients (NSEP, N=2135, 2009-2017) and three National HIV Behavioral Surveillance IDU surveys (NHBS, N=1709, 2009-2015). RESULTS: The proportion of non-MSM PWID reporting any recent methamphetamine injection increased significantly from approximately 20% in 2009 to 65% in 2017. Most of this increase was attributable to injecting methamphetamine in combination with heroin (goofballs). PWID who injected goofballs were more likely to be younger, homeless or unstably housed, report daily injection, and self-report an opioid overdose in the past year than other PWID. The majority of PWID who injected methamphetamine reported sharing any injection equipment. Among these PWID, 43% of MSM had last shared injection equipment with a non-MSM. Eight percent of non-MSM men and 15% of women had last shared equipment with an MSM. CONCLUSIONS: Given non-trivial rates of sharing injection equipment with methamphetamine-using MSM, a population with an HIV prevalence of 40%, non-MSM who inject methamphetamine could be an emerging population at risk for acquiring HIV.
Authors: Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2007-05-01 Impact factor: 3.731
Authors: Kristen C Ochoa; Peter J Davidson; Jennifer L Evans; Judith A Hahn; Kimberly Page-Shafer; Andrew R Moss Journal: Drug Alcohol Depend Date: 2005-06-14 Impact factor: 4.492
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Kimberly C Brouwer; Patricia Case; Rebeca Ramos; Carlos Magis-Rodríguez; Jesus Bucardo; Thomas L Patterson; Steffanie A Strathdee Journal: Subst Use Misuse Date: 2006 Impact factor: 2.164
Authors: Lindsay M Jenkins; Caleb J Banta-Green; Charles Maynard; Susan Kingston; Michael Hanrahan; Joseph O Merrill; Phillip O Coffin Journal: J Urban Health Date: 2011-02 Impact factor: 3.671
Authors: Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall Journal: Lancet Date: 2010-07-16 Impact factor: 79.321
Authors: Kate Buchacz; Willi McFarland; Timothy A Kellogg; Lisa Loeb; Scott D Holmberg; James Dilley; Jeffrey D Klausner Journal: AIDS Date: 2005-09-02 Impact factor: 4.177
Authors: Hanne Thiede; Richard A Jenkins; James W Carey; Rebecca Hutcheson; Katherine K Thomas; Ronald D Stall; Edward White; Iris Allen; Roberto Mejia; Matthew R Golden Journal: Am J Public Health Date: 2008-04-29 Impact factor: 9.308
Authors: Joshua A Barocas; Jianing Wang; Brandon D L Marshall; Marc R LaRochelle; Amy Bettano; Dana Bernson; Curt G Beckwith; Benjamin P Linas; Alexander Y Walley Journal: Drug Alcohol Depend Date: 2019-05-08 Impact factor: 4.492
Authors: Mary A Hatch-Maillette; Robin Harwick; John S Baer; Elizabeth A Wells; Tatiana Masters; Audra Robinson; Kasie Cloud; Michelle Peavy; Katharina Wiest; Lynette Wright; Kathleen Dillon; Blair Beadnell Journal: Drug Alcohol Depend Date: 2019-04-18 Impact factor: 4.492
Authors: Raminta Daniulaityte; Sydney M Silverstein; Timothy N Crawford; Silvia S Martins; William Zule; Angela J Zaragoza; Robert G Carlson Journal: Subst Use Misuse Date: 2020-05-22 Impact factor: 2.164
Authors: Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello Journal: Int J Drug Policy Date: 2020-09-07
Authors: Heather Bradley; Elizabeth M Rosenthal; Meredith A Barranco; Tomoko Udo; Patrick S Sullivan; Eli S Rosenberg Journal: J Infect Dis Date: 2020-09-02 Impact factor: 5.226